FDA Inspection 681842 — Quest Diagnostics

Quest Diagnostics — FEI 1872752

The FDA completed an inspection of Quest Diagnostics on Sep 22, 2010 in Indianapolis, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 22, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Indianapolis, IN (United States)

Citations

IDCFRDescription
904421 CFR 600.10(b)Personnel capabilities